|
 |
|
CASE REPORT |
|
|
|
| Year : 2013 | Volume
: 8
| Issue : 3 | Page : 217-220 |
| |
An interesting case of Rathke's cleft cyst presenting as bilateral cryptorchidism
Babul Reddy Hanmayyagari1, Mounika Guntaka2, Sridevi Paladugu3
1 Department of Endocrinology, Employee State Insurance Hospital, Sanath Nagar, Hyderabad, India
2 Consultant Biochemist, Department of Lab Medicine, Prime hospital, Kukatpally-Hyderabad, Hyderabad, India
3 Department of Endocrinology, Apollo Hospital, Hyderguda, Hyderabad, Andhra Pradesh, India
| Date of Web Publication | 26-Dec-2013 |
Correspondence Address:
Babul Reddy Hanmayyagari
Flat No 507, Emerald Block, My Home Jewel, Madinaguda, Hyderabad - 500 049, Andhra Pradesh
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/1817-1745.123677
 Abstract | | |
Rathke's cleft cyst (RCC) are benign, epithelium-lined sellar and suprasellar cysts believed to originate from remnants of the Rathke pouch. Here, we report a rare case of entirely suprasellar RCC in a 4.5-year-old child causing hypopituitarism, who presented to us with bilateral cryptorchidism. Subsequently we discuss the distinct rarity of entirely suprasellar RCC presenting in this fashion and the relevant literature is also discussed.
Keywords: Cryptorchidism, hypopituitarism, Rathke′s cleft cyst, testicular descent
How to cite this article:
Hanmayyagari BR, Guntaka M, Paladugu S. An interesting case of Rathke's cleft cyst presenting as bilateral cryptorchidism. J Pediatr Neurosci 2013;8:217-20 |
| Introduction | |  |
Cryptorchidism, defined as the absence of at least one testis in the scrotum, [1] is a frequent condition in the pediatric population. It affects up to 9% of full-term newborns and up to 1.5% of 1-year-old boys. [2] The most common location for an undescended testicle is just outside the external ring (suprascrotal), followed by the inguinal canal followed by the abdomen. [3] Cryptorchidism occurs more commonly among patients with congenital disorders of testosterone secretion or action, secondary hypogonadism, testosterone biosynthetic defects, or insensitivity syndromes, abdominal wall defects, neural tube defects, cerebral palsy, [4] and various genetic syndromes [5] (e.g., trisomy 18, trisomy 13, Noonan syndrome, Prader-Willi syndrome More Details, and Laurence-Moon-Biedl syndrome).
Rathke cleft cysts (RCCs) are benign, epithelium-lined sellar and suprasellar cysts believed to originate from remnants of the Rathke pouch [6] lying between the pars anterior and the pars intermedia of the pituitary gland. RCCs commonly have a round, ovoid, or dumbbell shape. They are usually asymptomatic and are discovered incidentally, when radiographic or necropsy findings are reviewed. Most cysts are smaller than 2 cm in diameter. Symptomatic RCCs are uncommon, but cysts can enlarge and cause symptoms secondary to compression of the pituitary gland, pituitary stalk, optic chiasm, or hypothalamus. Atypical presentations for RCC include abscess formation within the cyst, aseptic meningitis or entirely suprasellar RCC. [7],[8] The differential diagnoses are cystic craniopharyngioma, arachnoid cyst, and cystic pitutary adenomas. Distinction among these remains a difficult preoperative problem, because the symptoms, signs, and biochemical and radiographic features of these lesions can mimic each other.
Here, we report a rare case of entirely suprasellar Rathke's cleft cyst (RCC) in a 4.5-year old child causing hypopituitarism, who presented to us with bilateral cryptorchidism. Although till date, a few cases of symptomatic RCCs have been reported in world literature, the condition continues to remain largely unknown to practicing clinicians. The current report intends to draw attention towards hypopituitarism as one of the etiology of cryptorchidism. To the best of our knowledge, this is the first case of entirely suprasellar RCC presenting in a child with cryptorchidism to be reported from world literature.
| Case Report | | |
A 4.5-year-old boy presented to the Pediatric Surgery Department with bilateral undescended testes for which surgery was planned. Upon evaluation for short stature at the department of endocrinology, he was found to be born to nonconsanguineous parents, at full term by normal vaginal delivery; there was no history of prolonged labor or birth asphyxia and his birth weight was 2.5 kg. Mother noticed bilateral undescended testes at the time of delivery, but was reassured by the doctor that testes would descend subsequently. There was no history of seizures or prolonged jaundice in the neonatal period, but his motor and mental milestones were delayed. He remained shorter than his peers and his sister who is 2 years younger is taller than him. There was no history of chronic systemic disease, hypothyroidism, or features suggestive of raised intracranial pressure. On examination, his height is 84 cm (<3 rd percentile), upper to lower segment ratio is 0.9 [Figure 1], standard deviation score was 4, weight was 13 kg, and head circumference was 51 cm. He had frontal bossing, doll-like facies, central obesity, micropenis with stretched penile length of 2 cm, and both gonads were palpable in suprascrotal area with a poorly developed empty scrotal sac. His vitals and systemic examination were normal. | Figure 1: Showing child with short stature, central obesity, micro penis.
Click here to view |
Investigations revealed a hemoglobin of 13.6 g% (11-15), total lymphocyte count of 5,600/mm 3 (4-11,000), erythrocyte sedimentation rate of 15 (5-20), random blood sugar of 94 mg% (90-130), creatinine 0.8 mg/dl (0.6-1.5), free thyroxine (T4)-0.9 ng/ml (0.93-1.7), thyroid stimulating hormone (TSH)-7.27 mIU/ml (0.3-5.5), bone age-1 year, basal cortisol-13.76 μg/dl (8-20), follicle stimulating hormone (FSH)-0.63 mIU/dl (1.5-10.2), luteinizing hormone (LH)-0.1 mIU/dl (1.9-12), testosterone basal 0.025 ng/ml (3-6.5), stimulated testosterone with human chorionic gonadotropin (hCG) was 0.68 ng/ml (suggestive of normally functioning testes), and insulin-like growth factor 1 (IGF-1) was undetectable. Radiological evaluation revealed bilateral suprascrotal testes in ultrasound abdomen, a 3.8 × 3.6 cm suprasellar cystic lesion with compressed pituitary gland in magnetic resonance imaging (MRI) brain [Figure 2] and [Figure 3], which was hypointense on T 1 and hyperintense on T 2 images suggestive of cystic craniopharyngioma or Rathke's cyst. Child did not cooperate for an accurate visual field examination, but grossly he had some degree of visual impairment in left eye. Urine output and fluid input both were approximately 1 l. | Figure 2: Magnetic resonance imaging (MRI) sagittal section is showing suprasellar Rathke's cleft cyst (RCC) with normal compressed pituitary
Click here to view |
Child was subsequently treated with levothyroxine replacement in view of secondary hypothyroidism. After 4 weeks (with the normalization of T4 levels), he underwent right frontotemporal orbitozygomatic craniotomy, marsupialization of suprasellar cyst along with biopsy. His intra- and postoperative period was uneventful. Biopsy revealed a single-cell layered, cuboidal epithelium, suggesting a Rathke's cleft cyst. So the final diagnosis was Rathke's cleft cyst with hypopituitarism. At 6 and 12 weeks after surgery, child was reevaluated for pituitary function, which revealed persistent secondary hypothyroidism and low IGF-1 levels suggestive of growth hormone deficiency. Levothyroxine was reinstituted followed by initiation of growth hormone replacement along with 5 week hCG therapy (intramuscular (IM) 1,000 IU twice a week). This enabled gonadal descent into the scrotum 3 months after the completion of therapy.
| Discussion | | |
RCCs are usually located in an intrasellar or combined intra- and suprasellar location, between the pars anterior and the pars intermedia of the pituitary gland; they are assumed to be benign remnants of the craniopharyngeal duct, which is part of Rathke's pouch. The pars tuberalis of the pituitary gland which lies above the diaphragma sellae, is also derived from Rathke's pouch, and is the site of origin of entirely suprasellar RCCs. [9],[10] But purely suprasellar RCC are distinctly uncommon in clinical practice.
Majority of the RCC are asymptomatic. If the normal involution of Rathke's pouch fails to occur, the resulting RCC may increase in size by accumulation of cyst fluid and compress the surrounding structures with ensuing headache, visual problems, and hypopituitarism. [11],[12] Entirely suprasellar symptomatic RCCs with normal sella turcica are exceptionally rare and very few case reports are available in world literature. [10],[13] Further, RCC presenting at such a young age with hypopituitarism has not been reported till date.
Testicular descent occurs in two phases, comprising of transabdominal and inguinoscrotal descent, which occur approximately during the first and last thirds of gestation, respectively. Key anatomical events to release the testis from its urogenital ridge location and to guide the free gonad into the scrotum are the degeneration of the craniosuspensory ligament and a thickening of the gubernaculum. Androgens play a role in both these processes, particularly with respect to enabling the testis to traverse the inguinal canal in the final phase of descent. Androgen induces regression of the craniosuspensory ligament to release the testis to descend. Otherwise, androgens are not required for the first phase of testis descent. The thickening of the gubernaculum, a process crucial for anchoring the testis to the inguinal region is controlled by insulin-like 3 peptide (INSL3) and its G protein coupled receptor (GREAT). [14] In turn, this INSL3 is controlled by hCG and LH. [15]
Even though surgical management is the cornerstone of treatment for cryptorchidism, medical treatment can be effective in the above mentioned endocrine disorders and it is prudent to give a trial before resorting to orchiopexy. Available agents are gonadotropin releasing hormone (GnRH) or hCG injections that produce a significant rise in local testosterone levels; [16] thereby facilitating testicular descent. Commonly used agent is hCG and there are many protocols for the use of hCG. [16],[17],[18] One such protocol is the administration of 1,000-2,500 IU two times per week intramuscularly for 4-5 weeks. Whatever protocol is used, the likelihood of success is greatest in the most distal true undescended testicles. Complete success was defined as full descent of the testicle into the scrotum and needs assessment between 8 weeks and 6 months after the completion of treatment. These studies have reported temporary virilizing side effects, including increased penile length, erections, and testicular enlargement associated with hormonal treatment. All side effects were transitory.
In the present case, RCC causing a pressure effect on pituitary with subsequent inhibitory effect on the release of FSH, LH, growth hormone (GH), and TSH led to the hypogonadism (perhaps, the RCC was causing this pressure effect from the intrauterine period itself and hence resulted in cryptorchidism) along with hyposomatotropism and hypothyroidism. We also propose that because of its chronic compressive effect with consequent ischemic and pressure necrosis, all cell lineages were affected irreversibly as evidenced by no recovery of pituitary function in the post-surgical reevaluation. After hCG therapy, gonads descended into the scrotum and the patient is on long-term follow-up with replacement of levothyroxine and growth hormone.
| Conclusion | | |
In conclusion, RCCs are usually intrasellar or combined intra- and suprasellar, can rarely occur in an entirely suprasellar location with intact diaphragm and intact sella turcica, but a presentation as in our case, with features of hypopituitarism at such a young age, is distinctly uncommon. In the evaluation of cryptorchidism one should explore the possibility of central causes in the etiology, as this may respond to medical therapy, thereby obviating the need for unnecessary surgical intervention.
| References | | |
| 1. | Cortes D. Cryptorchidism - aspects of pathogenesis, histology and treatment. Scand J Urol Nephrol Suppl 1998;196:1-54. 
[PUBMED] |
| 2. | Boisen KA, Kaleva M, Main KM, Virtanen HE, Haavisto AM, Schmidt IM, et al. Difference in prevalence of congenital cryptorchidism in infants between two Nordic countries. Lancet 2004;363:1264-9.
[PUBMED] |
| 3. | Ferrer FA, McKenna PH. Current approaches to the undescended testicle. Contemp Pediatr 2000;17:106.
|
| 4. | Rundle JS, Primrose DA, Carachi R. Cryptorchism in cerebral palsy. Br J Urol 1982;54:170-1.
[PUBMED] |
| 5. | Marshall FF. Anomalies associated with cryptorchidism. Urol Clin North Am 1982;9:339.
[PUBMED] |
| 6. | Voelker JL, Campbell RL, Muller J. Clinical, radiographic, and pathological features of symptomatic Rathke′s cleft cysts. J Neurosurg 1991;74:535-44.
[PUBMED] |
| 7. | Obenchain TG. Abscess formation in a Rathke′s cleft cyst. J Neurosurg 1972;36:359-62.
|
| 8. | Wolfsohn AL, Lach B, Benoit BG. Suprasellar xanthomatous Rathke′s cleft cyst. Surg Neurol 1992;38:106-9.
[PUBMED] |
| 9. | Barrow DL, Spector RH, Takei Y, Tindall GT. Symptomatic Rathke′s cleft cysts located entirely in the suprasellar region: Review of diagnosis, management, and pathogenesis. Neurosurgery 1985;16:766-72.
[PUBMED] |
| 10. | Itoh J, Usui K. An entirely suprasellar symptomatic Rathke′s cleft cyst: Case report. Neurosurgery 1992;30:581-5.
[PUBMED] |
| 11. | Steinberg GK, Koenig GH, Golden JB. Symptomatic Rathke′s cleft cysts. Report of two cases. J Neurosurg 1982;56:290-5.
[PUBMED] |
| 12. | Keyaki A, Kim YJ, Nabeshima S. Clinical study of symptomatic Rathke cleft cyst. No Shinkei Geka 1999;27:625-31.
[PUBMED] |
| 13. | Wenger M, Simko M, Markwalder R, Taub E. An entirely suprasellar Rathke′s cleft cyst: Case report and review of the literature. J Clin Neurosci 2001;8:564-7.
[PUBMED] |
| 14. | Yamazawa K, Wada U, Sasagawa I, Aoki K, Katsuhiko U, Ogata T. Mutation and polymorphism analyses of INSL3 and LGR8/GREAT in 62 Japanese patients with cryptorchidism. Horm Res 2007;67:73-6.
|
| 15. | Foresta C, Zuccarello D, Garolla A, Ferlin A. Role of hormones, genes and environment in human cryptorchidism. Endocr Review 2008;29:560-80.
|
| 16. | Henna MR, Del Nero RG, Sampaio CZ, Atallah AN, Schettini ST, Castro AA, et al. Hormonal cryptorchidism therapy: Systematic review with metanalysis of randomized clinical trials. Pediatr Surg Int 2004;20:357-9.
[PUBMED] |
| 17. | Aycan Z, Ustunsalih-Inan Y, Cetinkaya E, Vidinlisan S, Ornek A. Evaluation of low-dose hCG treatment for cryptorchidism. Turk J Pediatr 2006;48:228-31.
|
| 18. | Hesse V, Fischer G. Three injections of human chorionic gonadotropin are as effective as ten injections in the treatment of cryptorchidism. Horm Res 1988;30:193-7.
[PUBMED] |
[Figure 1], [Figure 2], [Figure 3]
|
